Company
Anteris Technologies Ltd
Headquarters: Toowong, QLD, Australia
CEO: Mr. Wayne G. Paterson
Market Cap
A$347.9 Million
AUD as of July 1, 2024
US$231.7 Million
Anteris Technologies Ltd Categories
Australia Healthcare Medical DevicesAustralia Healthcare Australia Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Dec. 31, 2022 |
| Revenue TTM | A$4.1 M |
| EBITDA | A$-68,715,224 |
| Gross Profit TTM | A$2.6 M |
| Profit Margin | 56.83% |
| Operating Margin | -2250.30% |
| Quarterly Revenue Growth | -16.30% |
Stocks & Indices
Anteris Technologies Ltd has the following listings and related stock indices.
Stock: ASX: AVR wb_incandescent